Health news

  1. New prices negotiated! Reductions for 38 products

    Price decreases for 38 medicines

    Read more »
  2. New microneedle product could help people with ALS, MS and diabetes

    Remember the hypospray from Star Trek? Maybe it's close to reality.

    Star Trek magazine cover

    Read more »
  3. New medicines coming soon!

    A list of medicines TheSocialMedwork will soon be making available.

    New medicines

    Read more »
  4. Promising Developments in Treatment of Multiple Myeloma!

    Darzalex (daratumumab) combination under review as first-line option.

    Multiple Myeloma

    Read more »
  5. Spinraza, the new medicine for spinal muscular atrophy

    Is there substance to the claims that it's a groundbreaking treatment?

    Spinraza

    Read more »
  6. Why is there often a substantial delay in getting access to new medicines – even after they are approved?

    We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...

    Drug delays

    Read more »
  7. A new medicine for Alzheimer's disease?

    Introducing a breakthrough known as 'CT1812'

    alzheimer disease

    Read more »
  8. What is alectinib (Alecensa) and why is the latest news a positive step for lung cancer patients?

    How effective is alectinib (Alecensa)? The latest news and updates

    alecensa lung cancer

    Read more »
  9. Radicava is now available in the US – What does this mean for me?

    For US patients and patients worldwide with ALS.

    radicava USA

    Read more »
  10. Edaravone availability in the US - one month to go

    As we await the arrival of edaravone to US pharmacies, patients can access edaravone now through TheSocialMedwork.edaravone best price

    Read more »
Posts loader

One more step before you can continue

Our service contains information about acquiring medicines that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

Scroll down.

No, I'd like to receive general information only.

Disclaimer: The information TSM provides is aimed at patients with terminal and life-debilitating diseases, their doctors and healthcare professionals. It supports an informed decision by the treating doctor about the patient’s treatment and the consideration of a medicine which has not been approved in the patient’s country.